Jiangsu Recbio Technology Co., Ltd.
Status: Publicly traded
Direct answer
Jiangsu Recbio Technology Co., Ltd. is publicly traded on HKSE under the ticker 2179.HK.
Jiangsu Recbio Technology Co., Ltd. operates as a biotechnology company primarily engaged in the pioneering research, development, and eventual market introduction of subunit vaccines throughout the People's Republic of China. A significant portion of its pipeline is dedicated to combating human papillomavirus (HPV)-related diseases, including cervical cancer and genital warts. Its most advanced candidate, REC603,...
Can you invest in Jiangsu Recbio Technology Co., Ltd.?
Yes. Jiangsu Recbio Technology Co., Ltd. trades publicly on HKSE as 2179.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Jiangsu Recbio Technology Co., Ltd.
Detailed equity research is provided by MarketSnap.